Lenalidomide capsules
Active Awarded Last action
- Contract number
- 36C24726F0053
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $4,765,853
Award facts
- Contract value 100% obligated
- $4,765,853.07 Current and potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a delivery order valued at $4.77M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. This firm fixed-price contract, awarded on December 8, 2025, with an ultimate completion date of December 7, 2026, was issued without a set-aside designation, allowing full and open competition. The contract is performed in Boca Raton, Florida, where Exelan maintains its pharmaceutical manufacturing and distribution operations. Exelan Pharmaceuticals is a foreign-owned pharmaceutical company specializing in the manufacture, distribution, and repackaging of generic and branded pharmaceutical products for federal agencies, with established relationships across the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service.
This delivery order falls under Exelan's existing General Services Administration Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), leveraging the company's established federal pharmaceutical supply vehicle. The award reflects Exelan's core business model of providing bulk drug repackaging and patient-ready pharmaceutical distributions to support federal healthcare facilities. As part of the VA's pharmaceutical procurement strategy, this contract supports the provision of critical medications to the veteran healthcare system and is consistent with the company's historical contract portfolio, which includes numerous indefinite delivery contracts with ceiling values ranging up to $88M across various therapeutic categories and federal agencies.
Quick answers
Who was awarded contract 36C24726F0053?
36C24726F0053 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on December 8, 2025.
How much is contract 36C24726F0053 worth?
The government has obligated $4,765,853 on 36C24726F0053.
Is contract 36C24726F0053 an order under another contract?
Yes. 36C24726F0053 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24726F0053 competed?
The extent of competition for 36C24726F0053 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award